Tian S S, Tapley P, Sincich C, Stein R B, Rosen J, Lamb P
Ligand Pharmaceuticals, San Diego, CA 92121, USA.
Blood. 1996 Dec 15;88(12):4435-44.
Granulocyte colony-stimulating factor (G-CSF) is the major regulator of proliferation and differentiation of neutrophilic granulocyte precursor cells. G-CSF activates multiple signaling molecules, including the JAK1 and JAK2 kinases and the STAT transcription factors. To investigate G-CSF signaling events regulated by the JAK-STAT pathway, we have generated UT7-epo cells stably expressing either wild-type (wt) G-CSF receptor or a series of C-terminal deletion mutants. Gel mobility shift and immunoprecipitation/Western analysis showed that STAT5 is rapidly activated by G-CSF in cells expressing the wt G-CSF receptor, in addition to the previously reported STAT3 and STAT1. Mutants lacking any tyrosine residues in the cytoplasmic domain maintain their ability to activate STAT5 and STAT1 but cannot activate STAT3, implying that STAT5 and STAT1 activation does not require receptor tyrosine phosphorylation. We also observed significant changes in the ratio of STAT1:STAT3:STAT5 activated by various G-CSF receptor C-terminal deletion mutants. These mutant receptors were further used to investigate the role of JAKs and STATs in G-CSF-mediated responses in these cells. We found that JAK activation correlates with G-CSF-induced cell proliferation, whereas STAT activation is not required. We have also identified three classes of G-CSF immediate early genes, whose activation correlates with the activation of distinct JAK-STAT pathways. Our data show that, whereas c-fos is regulated through a pathway independent of STAT activation, oncostatin M, IRF-1, and egr-1 are regulated by an STAT5-dependent pathway and fibrinogen is regulated by an STAT3-dependent pathway. In conclusion, our results suggest that G-CSF regulates its complex biologic activities by selectively activating distinct early response genes through different JAK-STAT signaling molecules.
粒细胞集落刺激因子(G-CSF)是嗜中性粒细胞前体细胞增殖和分化的主要调节因子。G-CSF激活多种信号分子,包括JAK1和JAK2激酶以及STAT转录因子。为了研究由JAK-STAT途径调节的G-CSF信号事件,我们构建了稳定表达野生型(wt)G-CSF受体或一系列C末端缺失突变体的UT7-epo细胞。凝胶迁移率变动分析和免疫沉淀/蛋白质印迹分析表明,除了先前报道的STAT3和STAT1外,在表达wt G-CSF受体的细胞中,STAT5也能被G-CSF快速激活。在细胞质结构域中缺乏任何酪氨酸残基的突变体仍保持激活STAT5和STAT1的能力,但不能激活STAT3,这意味着STAT5和STAT1的激活不需要受体酪氨酸磷酸化。我们还观察到各种G-CSF受体C末端缺失突变体激活的STAT1:STAT3:STAT5比例有显著变化。这些突变受体被进一步用于研究JAK和STAT在这些细胞中G-CSF介导的反应中的作用。我们发现JAK激活与G-CSF诱导的细胞增殖相关,而STAT激活并非必需。我们还鉴定出三类G-CSF立即早期基因,它们的激活与不同JAK-STAT途径的激活相关。我们的数据表明,c-fos是通过一条独立于STAT激活的途径调节的,而抑瘤素M、IRF-1和egr-1是由一条依赖于STAT5的途径调节的,纤维蛋白原是由一条依赖于STAT3的途径调节的。总之,我们的结果表明,G-CSF通过不同的JAK-STAT信号分子选择性激活不同的早期反应基因来调节其复杂的生物学活性。